Reduce turn-around times with streamlined NGS Panels
Simple, robust and precise NGS enrichment for any target
We understand your pain points
- Insufficient starting material
- Labor costs
- Uneven coverage
- Costly reruns
- Unique targets
So we built a simpler solution
Panels available for Illumina, MGI, and Thermo sequencers
Solid Tumor Panels
Targets include multi-cancer, breast, lung, and colon. Includes panels specialized to detect fusions and CNVs.
Blood Cancer Panels
Targets include myeloid cancers and myeloprolifitive neoplasm.
Inherited Disease Panels
Targets include cystic fibrosis, thalassemia, and BRCA1/BRCA2.
Custom Panels
Design your own custom panel with a one-day workflow via the ampPD™ primer design platform.
Find a panel that suits your targets or design your own
- All
- Solid tumors
- Blood cancers
- Inherited conditions
- Custom NGS
- PillarHS
ONCO/Reveal
Custom NGS Panels
Build your own NGS assay that fits your exact design criteria
ONCO/Reveal
BRCA1 & BRCA2 plus CNV Panel
Detect exon-level copy number variation (CNV) across the entire coding region of the BRCA1 and BRCA2 genes from FFPE or blood samples
ONCO/Reveal
Solid Tumor Panel
Interrogates key mutations in NSCLC, colorectal, pancreatic, GIST, thyroid cancer, melanomas, gliomas and other solid tumors
ONCO/Reveal
Myeloid NGS Panel
Interrogates 58 genes of interest most relevant to myeloid cancer
ONCO/Reveal
Essential MPN Panel
Simultaneously tests for key mutations within the MPL, JAK2, and CALR genes
ONCO/Reveal
Multi-Cancer v4
with CNV Panel
Interrogates genes of interest across multiple solid tumor cancer types for variants and CNVs
ONCO/Reveal
Multi-Cancer
RNA Fusion v2 Panel
Detect gene fusions in solid tumor samples for cancers including NSCLC, thyroid, and prostate cancer
ONCO/Reveal
Multi-Cancer
with CNV & RNA Fusion Panel
A combined DNA/RNA multi-cancer panel that reports on variants, CNVs and fusions
ONCO/Reveal
Multi-Cancer Panel
Interrogate 56 genes of interest across multiple solid tumor cancer types
ONCO/Reveal
PillarHS Multi-Cancer Panel
Interrogates 31 genes of interest across multiple solid tumor cancer types from cell-free DNA samples (liquid biopsies)
ONCO/Reveal
PillarHS Lung Panel
Interrogates 17 lung cancer genes of interest from liquid biopsy samples
ONCO/Reveal
Lung and Colon Cancer Panel
Interrogate 22 genes of interest that are focused on lung and colon cancer samples
ONCO/Reveal
Lung Fusion RNA Panel
Interrogates gene fusions across non-small cell lung cancer (NSCLC) samples
ONCO/Reveal
BRCA1 & BRCA2 Panel
Sequence the entire coding regions of the BRCA1 and BRCA2 genes plus 20bp of flanking introns
ONCO/Reveal
BRCA1 & BRCA2 Somatic Panel
Specifically designed with shorter amplicons to detect mutations in FFPE samples
ONCO/Reveal
TP53 Panel
Covers the entire CDS of the TP53 tumor suppressor gene
INHERIT/Reveal
CFTR Panel
Covers the entire CDS of the cystic fibrosis transmembrane conductance regulator (CFTR) gene; can multiplex up to 384 samples on a MiSeq cartridge
INHERIT/Reveal
Thalassemia Panel
Covers mutations in the hemoglobin alpha chain (HBA1 and HBA2) and beta chain (HBB), which are responsible for alpha and beta thalassemia
Coming soon!
-MSI
-cfDNA /cfRNA (single tube)
-Glioma
-HRD
-Lynch Syndrome
Dive straight into the feedback!Login below and you can start commenting using your own user instantly